fr   en
Agreement

Tableaux synoptiques (en anglais)


Parcourir par date
Rechercher par mot clé
Date: 2006-01-16
Biotech partner: BioFocus DPI/Galapagos (Belgium)
Pharma Partner: Boehringer Ingelheim (Germany)
Type of agreement: * R&D
Compound: drug targets
Disease area: autoimmune diseases
Nature of the agreement: This autoimmune discovery research agreement is a new three year collaboration between BioFocus and Boehringer Ingelheim. BioFocus will apply its SilenceSelect® si-RNA based gene collection to run a target discovery screen for Boehringer's autoimmune discovery research..
Financial terms of the agreement: The total potential contract value may exceed €2 million.


Go back to previous page